CLINICAL
APPLICATIONS & DISEASE - Pharmaceuticals
Clinical
Applications & Disease > Pharmaceuticals
Summary from:
"Effects of flurbiprofen and indomethacin on acute cystoid macular
edema after cataract surgery: Functional vision and contrast sensitivity."
(In references, see: Ginsburg
AP, et al. Effects of flurbiprofen and indomethacin on acute cystoid
macular edema after cataract surgery: Functional vision and contrast
sensitivity.)
The effect of acute
cystoid macular edema (CME) on contrast sensitivity was examined. Eyedrops
were instilled into the surgically treated eye four times daily for
two days preoperatively and for three months postoperatively. Angiographic
and clinical CME were measured, as were contrast sensitivity and Snellen
acuity. Jaeger visual acuity equivalents were calculated and digital
imaging techniques used to simulate visual function. It was found that
angiographic CME reduces functional vision as measured by contrast sensitivity
and visual acuity over a large range of sizes. In patients treated with
the flurbiprofen vehicle, those without CME had higher mean contrast
sensitivity scores than those with CME; this increased over time. Those
treated with flurbiprofen and indomethacin had slightly higher contrast
sensitivity scores than vehicle-treated patients; this also increased
over time, most notably in the higher spatial frequencies. Flurbiprofen
treatment improved contrast sensitivity in patients with and without
CME significantly at 12 cycles per degree. Flurbiprofen-treated patients
with CME, in general, had higher contrast sensitivity scores than vehicle-treated
patients. In this population of patients having cataract surgery, treatment
with flurbiprofen or indomethacin reduced the loss of functional vision
associated with CME.
Clinical
Applications & Disease > Pharmaceuticals